GPRC5D
gene geneOn this page
Summary
GPRC5D (G protein-coupled receptor class C group 5 member D, HGNC:13310) is a protein-coding gene on chromosome 12p13.1, encoding G-protein coupled receptor family C group 5 member D (Q9NZD1). G-protein coupled receptor involved in hard keratin expression and likely plays a role in the development of hair and nails.
The protein encoded by this gene is a member of the G protein-coupled receptor family; however, the specific function of this gene has not yet been determined.
Source: NCBI Gene 55507 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 45 total
- Druggable target: yes
- MANE Select transcript:
NM_018654
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13310 |
| Approved symbol | GPRC5D |
| Name | G protein-coupled receptor class C group 5 member D |
| Location | 12p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000111291 |
| Ensembl biotype | protein_coding |
| OMIM | 607437 |
| Entrez | 55507 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000228887, ENST00000396333
RefSeq mRNA: 1 — MANE Select: NM_018654
NM_018654
CCDS: CCDS8658
Canonical transcript exons
ENST00000228887 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000721894 | 12949490 | 12950429 |
| ENSE00000822078 | 12942261 | 12942328 |
| ENSE00003963254 | 12940575 | 12940849 |
| ENSE00003963354 | 12952107 | 12952170 |
Expression profiles
Bgee: expression breadth ubiquitous, 155 present calls, max score 83.01.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1175 / max 52.3835, expressed in 24 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 129772 | 0.1047 | 23 |
| 129773 | 0.0128 | 6 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.01 | silver quality |
| pancreatic ductal cell | CL:0002079 | 77.12 | silver quality |
| upper lobe of left lung | UBERON:0008952 | 74.76 | gold quality |
| tibialis anterior | UBERON:0001385 | 73.98 | silver quality |
| diaphragm | UBERON:0001103 | 73.89 | gold quality |
| hair follicle | UBERON:0002073 | 73.69 | gold quality |
| upper lobe of lung | UBERON:0008948 | 72.03 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 71.79 | gold quality |
| rectum | UBERON:0001052 | 70.91 | gold quality |
| right lung | UBERON:0002167 | 70.88 | gold quality |
| minor salivary gland | UBERON:0001830 | 69.89 | gold quality |
| olfactory bulb | UBERON:0002264 | 67.98 | gold quality |
| type B pancreatic cell | CL:0000169 | 67.72 | gold quality |
| bone marrow cell | CL:0002092 | 66.72 | gold quality |
| mouth mucosa | UBERON:0003729 | 66.07 | gold quality |
| esophagus mucosa | UBERON:0002469 | 65.99 | gold quality |
| ileal mucosa | UBERON:0000331 | 65.97 | silver quality |
| saliva-secreting gland | UBERON:0001044 | 65.94 | gold quality |
| islet of Langerhans | UBERON:0000006 | 64.73 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 64.12 | gold quality |
| skin of abdomen | UBERON:0001416 | 62.78 | gold quality |
| right lobe of liver | UBERON:0001114 | 62.60 | gold quality |
| skin of leg | UBERON:0001511 | 62.52 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 61.93 | gold quality |
| right atrium auricular region | UBERON:0006631 | 61.72 | gold quality |
| colonic epithelium | UBERON:0000397 | 61.56 | gold quality |
| lung | UBERON:0002048 | 61.56 | gold quality |
| thyroid gland | UBERON:0002046 | 61.09 | gold quality |
| endothelial cell | CL:0000115 | 61.01 | gold quality |
| zone of skin | UBERON:0000014 | 60.87 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.15 |
| E-CURD-10 | no | 81.73 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma. (PMID:22591013)
- GPRC5D in MM cells makes this gene and its encoded surface protein as promising markers for monitoring the tumor load and hopefully also as targets for antimyeloma antibodies. (PMID:23510526)
- GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer. (PMID:37574551)
- Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation. (PMID:37653140)
- Genetic Basis of Relapse after GPRC5D-Targeted CAR T Cells. (PMID:37819961)
- GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. (PMID:38307865)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| ENSDARG00000099947 | ||
| mus_musculus | Gprc5d | ENSMUSG00000030205 |
| rattus_norvegicus | Gprc5d | ENSRNOG00000008439 |
Paralogs (3): GPRC5A (ENSG00000013588), GPRC5B (ENSG00000167191), GPRC5C (ENSG00000170412)
Protein
Protein identifiers
G-protein coupled receptor family C group 5 member D — Q9NZD1 (reviewed: Q9NZD1)
All UniProt accessions (1): Q9NZD1
UniProt curated annotations — full annotation on UniProt →
Function. G-protein coupled receptor involved in hard keratin expression and likely plays a role in the development of hair and nails.
Subunit / interactions. Homodimer.
Subcellular location. Cell membrane.
Tissue specificity. Widely expressed in the peripheral system. Expression pattern is high in pancreas, medium in kidney, small intestine, spleen and testis, low in lung, colon, leukocyte, prostate and thymus and not detectable in brain, heart, liver, placenta, skeletal muscle and ovary.
Similarity. Belongs to the G-protein coupled receptor 3 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NZD1-1 | 1 | yes |
| Q9NZD1-2 | 2 | |
| Q9NZD1-3 | 3 |
RefSeq proteins (1): NP_061124* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR017978 | GPCR_3_C | Domain |
| IPR051753 | RA-inducible_GPCR3 | Family |
Pfam: PF00003
UniProt features (40 total): helix 12, topological domain 8, transmembrane region 7, turn 5, splice variant 3, strand 3, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9IMA | ELECTRON MICROSCOPY | 2.65 |
| 8YZK | ELECTRON MICROSCOPY | 3.4 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NZD1-F1 | 76.43 | 0.44 |
Antibody-complex structures (SAbDab): 2 — 8YZK, 9IMA
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 70 (showing top):
NKX25_02, AAAYRNCTG_UNKNOWN, GOMF_KINASE_ACTIVATOR_ACTIVITY, MARTINEZ_RB1_TARGETS_DN, TATA_C, AACTTT_UNKNOWN, GFI1_01, MODULE_207, MODULE_342, ZHAN_MULTIPLE_MYELOMA_CD2_DN, GOCC_RECEPTOR_COMPLEX, GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, SMAD_Q6
GO Biological Process (2): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), protein kinase activator activity (GO:0030295), protein binding (GO:0005515)
GO Cellular Component (4): plasma membrane (GO:0005886), signaling receptor complex (GO:0043235), extracellular exosome (GO:0070062), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| protein kinase activity | 1 |
| kinase activator activity | 1 |
| protein kinase regulator activity | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| protein-containing complex | 1 |
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
414 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPRC5D | FCRL5 | Q96RD9 | 819 |
| GPRC5D | CEP70 | Q8NHQ1 | 705 |
| GPRC5D | SLAMF7 | Q9NQ25 | 696 |
| GPRC5D | TNFRSF17 | Q02223 | 571 |
| GPRC5D | CD38 | P28907 | 554 |
| GPRC5D | SDC1 | P18827 | 522 |
| GPRC5D | CCL4 | P13236 | 477 |
| GPRC5D | GPR156 | Q8NFN8 | 476 |
| GPRC5D | TNFRSF13B | O14836 | 446 |
| GPRC5D | CD19 | P15391 | 440 |
| GPRC5D | KRTAP4-16 | G5E9R7 | 399 |
| GPRC5D | LY9 | Q9HBG7 | 398 |
| GPRC5D | ITGB7 | P26010 | 370 |
| GPRC5D | TNFRSF9 | Q07011 | 370 |
| GPRC5D | CRBN | Q96SW2 | 357 |
IntAct
98 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BTN2A2 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| TWSG1 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM19 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| OSMR | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYNDIG1 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 | |
| FXYD3 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRAC | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHFPL5 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| LRRC25 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| PVR | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| IGFBP5 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A6A | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| UNC93B1 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC66A1 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM79 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC30A2 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| IFITM3 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| PMP22 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM208 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| EMP1 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCL4 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPRC5D | YIPF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TUSC5 | GPRC5D | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (72): SEC63 (Affinity Capture-MS), VPS45 (Affinity Capture-MS), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), GPRC5D (Two-hybrid), IGFBP5 (Two-hybrid), BTN2A2 (Two-hybrid), APOL3 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTI8, A0A2Z2U4G9, A0A494BA31, A5D6W6, A6NC51, A6NDP7, A6NFC5, A6NH21, A6NJY4, A8WCG0, B0BNG2, B1AQL3, E9Q9H8, O43246, P43219, P48546, Q1HG43, Q1HG44, Q2KIG8, Q32L10, Q497B3, Q49LS0, Q49LS7, Q4VV71, Q53RY4, Q58CW5, Q5REM8, Q5XK03, Q658P3, Q6PEY1, Q6UW68, Q80SU6, Q8C0T0, Q8K177, Q8K4R8, Q8K4V2, Q8N130, Q8VE49, Q91XE8, Q923Z0
Diamond homologs: Q2YDG0, Q3KRC4, Q8BHL4, Q8K3J9, Q8NFJ5, Q923Z0, Q9JIL6, Q9NQ84, Q9NZD1, Q9NZH0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 32 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| intracellular protein transport | 5 | 12.5× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 40 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
365 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:12942329:C:CC | acceptor_gain | 0.9800 |
| 12:12949489:CCT:C | donor_gain | 0.9800 |
| 12:12949485:TGTAC:T | donor_loss | 0.9600 |
| 12:12949486:GTAC:G | donor_loss | 0.9600 |
| 12:12949487:TAC:T | donor_loss | 0.9600 |
| 12:12949488:ACCT:A | donor_loss | 0.9600 |
| 12:12949489:C:T | donor_loss | 0.9600 |
| 12:12949501:T:TA | donor_gain | 0.9500 |
| 12:12949554:G:A | donor_gain | 0.9500 |
| 12:12940846:CAGT:C | acceptor_gain | 0.9400 |
| 12:12949662:G:GT | donor_gain | 0.9400 |
| 12:12942328:GCT:G | acceptor_loss | 0.9200 |
| 12:12942329:C:G | acceptor_loss | 0.9200 |
| 12:12942330:T:G | acceptor_loss | 0.9200 |
| 12:12942331:G:C | acceptor_loss | 0.9200 |
| 12:12942337:C:CT | acceptor_gain | 0.9200 |
| 12:12949491:T:TA | donor_gain | 0.9100 |
| 12:12940850:C:CC | acceptor_gain | 0.9000 |
| 12:12942337:C:T | acceptor_gain | 0.9000 |
| 12:12942338:A:T | acceptor_gain | 0.8800 |
| 12:12942325:CGGG:C | acceptor_gain | 0.8700 |
| 12:12949490:C:G | donor_loss | 0.8700 |
| 12:12942333:A:C | acceptor_loss | 0.8600 |
| 12:12948077:GCTAC:G | acceptor_gain | 0.8600 |
| 12:12949460:C:A | donor_gain | 0.8500 |
| 12:12949483:AATGT:A | donor_loss | 0.8500 |
| 12:12949484:ATGTA:A | donor_loss | 0.8500 |
| 12:12942332:AAA:A | acceptor_loss | 0.8400 |
| 12:12949420:A:AC | donor_gain | 0.8300 |
| 12:12949421:C:CC | donor_gain | 0.8300 |
AlphaMissense
2250 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:12949974:A:C | S137R | 0.991 |
| 12:12949974:A:T | S137R | 0.991 |
| 12:12949976:T:G | S137R | 0.991 |
| 12:12949634:A:G | W251R | 0.987 |
| 12:12949634:A:T | W251R | 0.987 |
| 12:12950145:G:C | F80L | 0.983 |
| 12:12950145:G:T | F80L | 0.983 |
| 12:12950147:A:G | F80L | 0.983 |
| 12:12949727:A:G | W220R | 0.981 |
| 12:12949727:A:T | W220R | 0.981 |
| 12:12949736:A:G | W217R | 0.981 |
| 12:12949736:A:T | W217R | 0.981 |
| 12:12949638:G:C | N249K | 0.979 |
| 12:12949638:G:T | N249K | 0.979 |
| 12:12950097:A:C | F96L | 0.979 |
| 12:12950097:A:T | F96L | 0.979 |
| 12:12950099:A:G | F96L | 0.979 |
| 12:12950178:A:C | S69R | 0.977 |
| 12:12950178:A:T | S69R | 0.977 |
| 12:12950180:T:G | S69R | 0.977 |
| 12:12950288:C:G | G33R | 0.977 |
| 12:12949875:A:C | F170L | 0.975 |
| 12:12949875:A:T | F170L | 0.975 |
| 12:12949877:A:G | F170L | 0.975 |
| 12:12950085:A:C | F100L | 0.975 |
| 12:12950085:A:T | F100L | 0.975 |
| 12:12950087:A:G | F100L | 0.975 |
| 12:12950069:A:G | C106R | 0.973 |
| 12:12950171:C:G | G72R | 0.969 |
| 12:12950171:C:T | G72R | 0.969 |
dbSNP variants (sampled 300 via entrez): RS1000064075 (12:12943032 C>T), RS1000168465 (12:12948551 T>A), RS1000399523 (12:12947958 G>T), RS1000505118 (12:12947299 A>C,G), RS1000682054 (12:12941679 C>T), RS1000766562 (12:12947001 A>G), RS1001112749 (12:12953733 C>G), RS1002183999 (12:12945338 G>A), RS1002353852 (12:12941906 C>T), RS1002422869 (12:12945028 G>A), RS1002430123 (12:12953081 C>A), RS1002756632 (12:12943533 C>G), RS1002804564 (12:12944386 C>A), RS1002856866 (12:12944604 G>A), RS1003186866 (12:12946123 A>G)
Disease associations
OMIM: gene MIM:607437 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523925 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class C Orphans
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| afimoxifene | affects response to substance | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arbutin | decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Zinc | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883479 | Binding | PRESTO-Tango GPCRome screening (GPRC5D) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
5 cell lines: 3 cancer cell line, 1 spontaneously immortalized cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E6QM | Genomeditech CHO-K1 H_GPRC5D | Spontaneously immortalized cell line | Female |
| CVCL_E6U1 | Genomeditech HEK-293 H_GPRC5D | Transformed cell line | Female |
| CVCL_E6WJ | Genomeditech MC-38 H_GPRC5D | Cancer cell line | Female |
| CVCL_E8JB | BxPC-3 human GPRC5D-HA | Cancer cell line | Female |
| CVCL_E8JD | BxPC-3 human GPRC5D | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Talquetamab